Suzhou Lixin Pharmaceutical

Orienting at international markets and insisting on the innovation of production process and patent protection, Lixin focuses on the research and development of both patented and generic drugs. We have developed a series of APIs including Antineoplastic drugs, Cardiovascular drugs, Nootropic drugs, Antiplatelet drugs etc. We also put emphasis on overseas dossiers submissions including DMFs, CTDs and many country registrations. All these efforts have brought us favorable feedbacks from our customers.